Revvity Price to Sales Ratio 2010-2024 | RVTY
Historical PS ratio values for Revvity (RVTY) over the last 10 years. The current P/S ratio for Revvity as of December 20, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Revvity P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-12-20 | 112.56 | 5.16 | |
| 2024-09-30 | 127.68 | $21.80 | 5.86 |
| 2024-03-31 | 104.80 | $21.89 | 4.79 |
| 2023-12-31 | 109.03 | $21.97 | 4.96 |
| 2023-09-30 | 110.34 | $22.25 | 4.96 |
| 2023-06-30 | 118.33 | $22.46 | 5.27 |
| 2023-03-31 | 132.68 | $22.43 | 5.92 |
| 2022-12-31 | 139.54 | $24.17 | 5.77 |
| 2024-06-30 | 104.73 | $25.91 | 4.04 |
| 2022-09-30 | 119.68 | $24.00 | 4.99 |
| 2022-06-30 | 141.38 | $25.86 | 5.47 |
| 2022-03-31 | 173.35 | $20.88 | 8.30 |
| 2021-12-31 | 199.71 | $21.86 | 9.14 |
| 2021-09-30 | 172.05 | $25.43 | 6.77 |
| 2020-12-31 | 142.27 | $23.78 | 5.98 |
| 2020-09-30 | 124.36 | $28.91 | 4.30 |
| 2020-06-30 | 97.13 | $31.25 | 3.11 |
| 2020-03-31 | 74.48 | $30.33 | 2.46 |
| 2019-12-31 | 96.00 | $30.97 | 3.10 |
| 2021-06-30 | 153.24 | $29.57 | 5.18 |
| 2019-09-30 | 84.14 | $25.43 | 3.31 |
| 2019-06-30 | 95.10 | $25.12 | 3.79 |
| 2019-03-31 | 95.05 | $24.96 | 3.81 |
| 2018-12-31 | 77.42 | $24.91 | 3.11 |
| 2018-09-30 | 95.79 | $23.92 | 4.01 |
| 2018-06-30 | 72.05 | $22.88 | 3.15 |
| 2018-03-31 | 74.43 | $21.50 | 3.46 |
| 2017-12-31 | 71.81 | $20.38 | 3.52 |
| 2017-09-30 | 67.67 | $19.73 | 3.43 |
| 2017-06-30 | 66.79 | $19.41 | 3.44 |
| 2017-03-31 | 56.84 | $19.36 | 2.94 |
| 2016-12-31 | 50.99 | $19.17 | 2.66 |
| 2016-09-30 | 54.79 | $18.01 | 3.04 |
| 2016-06-30 | 51.12 | $18.30 | 2.79 |
| 2016-03-31 | 48.17 | $18.38 | 2.62 |
| 2015-12-31 | 52.09 | $18.54 | 2.81 |
| 2015-09-30 | 44.62 | $18.44 | 2.42 |
| 2015-06-30 | 51.04 | $18.24 | 2.80 |
| 2015-03-31 | 49.52 | $18.17 | 2.73 |
| 2014-12-31 | 42.28 | $18.72 | 2.26 |
| 2014-09-30 | 42.08 | $19.45 | 2.16 |
| 2014-06-30 | 45.13 | $19.49 | 2.32 |
| 2013-12-31 | 39.60 | $19.01 | 2.08 |
| 2013-09-30 | 36.19 | $18.72 | 1.93 |
| 2013-06-30 | 31.09 | $18.53 | 1.68 |
| 2013-03-31 | 32.12 | $18.29 | 1.76 |
| 2012-12-31 | 30.24 | $18.36 | 1.65 |
| 2012-09-30 | 28.01 | $18.20 | 1.54 |
| 2012-06-30 | 24.46 | $17.76 | 1.38 |
| 2012-03-31 | 26.15 | $17.42 | 1.50 |
| 2011-12-31 | 18.85 | $16.91 | 1.11 |
| 2011-09-30 | 18.04 | $15.72 | 1.15 |
| 2011-06-30 | 25.20 | $15.29 | 1.65 |
| 2010-12-31 | 24.05 | $14.41 | 1.67 |
| 2010-09-30 | 21.49 | $13.02 | 1.65 |
| 2010-06-30 | 19.13 | $13.36 | 1.43 |
| 2010-03-31 | 22.05 | $13.03 | 1.69 |
| 2009-12-31 | 18.93 | $13.46 | 1.41 |
| 2011-03-31 | 24.54 | $14.62 | 1.68 |
| 2009-09-30 | 17.63 | $22.36 | 0.79 |
| 2009-06-30 | 15.88 | $23.79 | 0.67 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.453B | $2.751B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $84.995B | 10.55 |
| Cencora (COR) | United States | $43.734B | 16.44 |
| DiDi Global (DIDIY) | China | $22.941B | 0.00 |
| Natera (NTRA) | United States | $20.871B | 0.00 |
| ICON (ICLR) | Ireland | $16.879B | 15.03 |
| Viatris (VTRS) | United States | $14.478B | 4.46 |
| Avantor (AVTR) | United States | $14.307B | 21.45 |
| BioMerieux (BMXMF) | France | $12.659B | 0.00 |
| CochLear (CHEOY) | Australia | $11.807B | 0.00 |
| Solventum (SOLV) | United States | $11.540B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.417B | 29.35 |
| Doximity (DOCS) | United States | $10.302B | 60.64 |
| Charles River Laboratories (CRL) | United States | $9.314B | 18.00 |
| HealthEquity (HQY) | United States | $8.212B | 41.20 |
| Sonic Healthcare (SKHHY) | Australia | $8.208B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.322B | 29.43 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.759B | 20.11 |
| Organon (OGN) | United States | $3.719B | 3.75 |
| BrightSpring Health Services (BTSG) | United States | $2.967B | 63.11 |
| Surgery Partners (SGRY) | United States | $2.493B | 28.42 |
| Concentras Parent (CON) | United States | $2.491B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.291B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.069B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| PACS (PACS) | United States | $1.992B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $1.969B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.730B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Teladoc Health (TDOC) | United States | $1.544B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.224B | 11.98 |
| Progyny (PGNY) | United States | $1.208B | 24.47 |
| Embecta (EMBC) | United States | $1.161B | 8.12 |
| CareDx (CDNA) | United States | $1.102B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.090B | 0.00 | |
| AMN Healthcare Services Inc (AMN) | United States | $0.874B | 5.91 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.775B | 0.00 |
| SBC Medicals (SBC) | United States | $0.649B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.492B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.478B | 0.00 |
| DocGo (DCGO) | United States | $0.444B | 16.73 |
| Sonida Senior Living (SNDA) | United States | $0.441B | 0.00 |
| Enhabit (EHAB) | United States | $0.387B | 33.48 |
| Sera Prognostics (SERA) | United States | $0.275B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.212B | 0.00 |
| Biodesix (BDSX) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.176B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| ModivCare (MODV) | United States | $0.156B | 8.44 |
| MultiPlan (MPLN) | United States | $0.108B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.099B | 0.00 |
| So-Young (SY) | China | $0.093B | 15.69 |
| IceCure Medical (ICCM) | Israel | $0.052B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.050B | 0.00 |
| OncoCyte (OCX) | United States | $0.037B | 0.00 |
| NeueHealth (NEUE) | United States | $0.033B | 0.87 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Oncology Institute (TOI) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| KindlyMD (KDLY) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |